Experimental and integrative analyses identify an ETS1 network downstream of BCR-ABL in chronic myeloid leukemia (CML)
- 1 August 2018
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 64, 71-83.e8
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survivalBlood, 2012
- Distinct Functional Effects for Dynamin 3 During MegakaryocytopoiesisStem Cells and Development, 2011
- Genomic and Biochemical Insights into the Specificity of ETS Transcription FactorsAnnual Review of Biochemistry, 2011
- Chronic myeloid leukemia: mechanisms of blastic transformationJournal of Clinical Investigation, 2010
- Transcriptional silencing of the ETS1 oncogene contributes to human granulocytic differentiationHaematologica, 2010
- A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinibBlood, 2010
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Down-regulation of BRCA1 in BCR-ABL–expressing hematopoietic cellsBlood, 2003
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001
- IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cellsOncogene, 2000